Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas.
Anna-Maria BarciszewskaPublished in: BMC cancer (2020)
We conclude that the total DNA methylation can be a useful marker for brain meningioma detection, differentiation, and monitoring. It correlates with tumor WHO grade, and the 5-methylcytosine level in peripheral blood reflects that in tumor tissue. Therefore it's applicable for liquid biopsy. Our study creates a scope for further research on epigenetic mechanisms in neurooncology and can lead to the development of new diagnostic methods in clinical practice.